Hummingbird Study: Results from an Exploratory Trial Assessing the Performance and Acceptance of a Digital Medicine System in Adults with Schizophrenia, Schizoaffective Disorder, or First-Episode Psychosis

PURPOSE: Symptoms of psychotic disorders can complicate efforts to accurately evaluate patients’ medication ingestion. The digital medicine system (DMS), composed of antipsychotic medication co-encapsulated with an ingestible sensor, wearable sensor patches, and a smartphone application, was develop...

Descripción completa

Detalles Bibliográficos
Autores principales: Fowler, J Corey, Cope, Nathan, Knights, Jonathan, Fang, Hui, Skubiak, Taisa, Shergill, Sukhi S, Phiri, Peter, Rathod, Shanaya, Peters-Strickland, Timothy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Clinical Trial Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7886232/
https://www.ncbi.nlm.nih.gov/pubmed/33603385
http://dx.doi.org/10.2147/NDT.S290793

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7886232/
https://www.ncbi.nlm.nih.gov/pubmed/33603385
http://dx.doi.org/10.2147/NDT.S290793

Ejemplares similares